These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Influence of statolon on resistance of mice to influenza. Pindak FF; Schmidt JP; Kendrick JZ Appl Microbiol; 1969 Aug; 18(2):147-51. PubMed ID: 4308934 [TBL] [Abstract][Full Text] [Related]
9. Immunization of mice against encephalomyocarditis virus. I. Purification, concentration, and inactivation of encephalomyocarditis virus. Bogaerts WJ; Durville-van der Oord Infect Immun; 1972 Oct; 6(4):508-12. PubMed ID: 4344026 [TBL] [Abstract][Full Text] [Related]
10. Role of immunity in viral-induced bacterial superinfections of the lung. Goldstein E; Akers T; Prato C Infect Immun; 1973 Nov; 8(5):757-61. PubMed ID: 4356071 [TBL] [Abstract][Full Text] [Related]
11. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis. Stringfellow DA; Overall JC; Glasgow LA J Infect Dis; 1974 Nov; 130(5):481-8. PubMed ID: 4371529 [No Abstract] [Full Text] [Related]
12. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection. Wheelock EF; Toy ST; Caroline NL; Sibal LR; Fink MA; Beverley PC; Allison AC J Natl Cancer Inst; 1972 Mar; 48(3):665-73. PubMed ID: 5062046 [No Abstract] [Full Text] [Related]
13. Effect of cyclophosphamide on the protective action of endotoxin in mice challenged with encephalomyocarditis virus. Rathová V; Kocisková D; Borecký L Acta Virol; 1972 May; 16(3):201-10. PubMed ID: 4402249 [No Abstract] [Full Text] [Related]
14. SOME PROPERTIES OF THE ENCEPHALOMYOCARDITIS, COLUMBIA SK AND MENGO VIRUSES. CRAIGHEAD JE Proc Soc Exp Biol Med; 1965 Jun; 119():408-12. PubMed ID: 14328905 [No Abstract] [Full Text] [Related]